|
|
|
| Once the decision to outsource commercial production is made, it is essential to select the right partner. An experienced CDMO will be able to help you address important considerations when it comes to identifying the best approach for your commercial manufacturing. Explore key considerations for biopharmaceutical companies as they advance their antibody drug to commercial manufacturing and navigate complexities associated with business planning, process scale-up, optimization and validation, technology considerations and regulatory compliance. Download guidebook. |
|
|
|
|
Melissa Leichter, a Novo Nordisk executive, describes the distinct skills and mindset needed to succeed in bringing rare disease treatments to market. |
|
|
|
|
|
|
| Integrated Solutions For Advanced Therapies | The right CDMO offering integrated services can ease increasingly common CGT manufacturing problems such as scale, raw material access, viral vector production, and quality requirements. |
|
|
| The Right EDC Solution For Oncology Trials | Oncology clinical trials can be very complex, as are their data management needs. Understand why selecting the right EDC is crucial for managing them efficiently while providing compassionate care. |
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
